Drug recall · August 30, 2023
Bendamustine HCl Injection recall
Why: Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
- Lots / codes
Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025
- Quantity
- 13,502 vials
- Company
- Baxter Healthcare Corporation, Deerfield, IL
- Distribution
- Nationwide in the U.S.A.
- Initiated
- August 14, 2023 · Voluntary: Firm initiated
- Classified
- August 24, 2023
- Reported
- August 30, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bendamustine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.